TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
INSM

Insmed Inc

Healthcare · Biotechnology

120.00$ -3.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement INSM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-100.0% +1,287.6% +20.5% +14.6% +30.2% +24.4% +19.2% +66.7%
-94.1% +23.0% +19.0% -16.5% +899.3% +64.7% +10.7% +24.9% +19.0% +30.8% +45.6%
+1,414.5% +10.9% +15.9% +31.8% +26.0% +16.0% +73.2%
+31.9% +65.2% -10.6% +32.4% -9.3% +37.5% +50.6% +45.7% +43.6% +4.8% +28.9%
+39.1% +17.3% +56.2% +112.5% +25.3% -3.4% +15.1% +13.5% +29.6% +33.9% +52.1%
+34.5% +47.6% +9.0% +66.6% +10.4% +12.2% +33.3% +24.7% +46.6% +21.8% +43.4%
+19.6% +21.1% +69.4% +329.9% +8.8% +6.7% +36.9% -34.7% +208.9% +3.9% -1.3%
-377.6% +286.6% +80.4% -225.4% +84.7% +45.1% +35.6%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?